Personal information

Other IDs

Scopus Author ID: 55904381900

Activities

Collapse all

Employment (1)

Azienda ULSS 9 Scaligera: Verona, Veneto, IT

2020-10-01 to present | Dirigente Medico di reumatologia (Medicina Generale)
Employment
Source: Self-asserted source
Bruno Lucchino

Works (12)

SARS-CoV-2-induced venous thromboembolism in a patient with VEXAS syndrome

Rheumatology Advances in Practice
2022-12-30 | Journal article
DOI: 10.1093/rap/rkad012
Contributors: Bruno Lucchino; Lorenzo Delfino; Giuseppe Patuzzo; Annacarla Finucci; Francesco Ghellere; Maria Elena Bortolotti; Sara Lombardi
Source: check_circle
Crossref

Influence of HLA polymorphisms on clinical features of VEXAS syndrome: a potential epistatic mechanism

Rheumatology
2022-12-23 | Journal article
DOI: 10.1093/rheumatology/keac371
Contributors: Bruno Lucchino; Annacarla Finucci; Francesco Ghellere; Maria Elena Bortolotti; Andrea Tedesco; Sara Lombardi
Source: check_circle
Crossref

Identification of Subclinical Lung Involvement in ACPA-Positive Subjects through Functional Assessment and Serum Biomarkers

International Journal of Molecular Sciences
2020-07-21 | Journal article
DOI: 10.3390/ijms21145162
Contributors: Bruno Lucchino; Marcello Di Paolo; Chiara Gioia; Marta Vomero; Davide Diacinti; Cristina Mollica; Cristiano Alessandri; Daniele Diacinti; Paolo Palange; Manuela Di Franco
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

COVID-19: an unexpected indication for anti-rheumatic therapies?

Rheumatology
2020-06-01 | Journal article
DOI: 10.1093/rheumatology/keaa194
Contributors: Bruno Lucchino; Manuela Di Franco; Fabrizio Conti
Source: check_circle
Crossref

Mucosa–Environment Interactions in the Pathogenesis of Rheumatoid Arthritis

Cells
2019-07 | Journal article
DOI: https://doi.org/10.3390/cells8070700
Source: Self-asserted source
Bruno Lucchino

Reactive arthritis: current treatment challenges and future perspectives.

Clinical and experimental rheumatology
2019-05-22 | Journal article
PMID: 31140399
Source: Self-asserted source
Bruno Lucchino

One year in review 2019: fibromyalgia.

Clinical and experimental rheumatology
2019-01-01 | Journal article
PMID: 30747097
Source: Self-asserted source
Bruno Lucchino

Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis

Mediators of Inflammation
2018 | Journal article
DOI: 10.1155/2018/3897295
Contributors: Manuela Di Franco; Bruno Lucchino; Fabrizio Conti; Guido Valesini; Francesca Romana Spinelli
Source: check_circle
Crossref

An unusual manifestation of IgG4-related disease

Rheumatology
2018-07-01 | Journal article
DOI: 10.1093/rheumatology/key050
Contributors: Roberta Priori; Bruno Lucchino; Bruna Cerbelli; Cristiano Alessandri; Valeria Bottaro; Alessio Zodda; Giulia D’Amati; Guido Valesini; Massimo Fusconi
Source: check_circle
Crossref

Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections

International Journal of Molecular Sciences
2017-01-29 | Journal article
DOI: 10.3390/ijms18020293
Part of ISSN: 1422-0067
Source: Self-asserted source
Bruno Lucchino

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

Core Evidence
2014-03 | Journal article
DOI: 10.2147/ce.s39770
Part of ISSN: 1555-175X
Source: Self-asserted source
Bruno Lucchino

Effect of Therapeutic Inhibition of TNF on Circulating Endothelial Progenitor Cells in Patients with Rheumatoid Arthritis

Mediators of Inflammation
2013 | Journal article
DOI: 10.1155/2013/537539
Part of ISSN: 0962-9351
Part of ISSN: 1466-1861
Source: Self-asserted source
Bruno Lucchino
How many people are using ORCID?